These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1706118)

  • 1. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
    Giles CM; Davies KA; Walport MJ
    Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
    Nordhagen R; Heier Larsen AM; Beckers D
    Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal anti-C4d that demonstrates a specificity related to anti-Ch.
    Giles CM; Ford DS
    Transfusion; 1986; 26(4):370-4. PubMed ID: 3523873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells.
    Judd WJ; Kraemer K; Moulds JJ
    Transfusion; 1981; 21(2):189-92. PubMed ID: 7222201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of the fourth component of complement related Chido and Rodgers blood group antigens.
    Atkinson JP; Chan AC; Karp DR; Killion CC; Brown R; Spinella D; Shreffler DC; Levine RP
    Complement; 1988; 5(2):65-76. PubMed ID: 2967744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo instability of red-blood-cell-bound C3d and C4d.
    Chaplin H; Coleman ME; Monroe MC
    Blood; 1983 Nov; 62(5):965-71. PubMed ID: 6605168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycophorin A-deficient red cells may have a weak expression of C4-bound Ch and Rg antigens.
    Tippett P; Storry JR; Walker PS; Okubo Y; Reid ME
    Immunohematology; 1996; 12(1):4-7. PubMed ID: 15387753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray crystal structure of the C4d fragment of human complement component C4.
    van den Elsen JM; Martin A; Wong V; Clemenza L; Rose DR; Isenman DE
    J Mol Biol; 2002 Oct; 322(5):1103-15. PubMed ID: 12367531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblotting human C4 bound to human erythrocytes in vivo and in vitro.
    Giles CM; Robson T
    Clin Exp Immunol; 1991 May; 84(2):263-9. PubMed ID: 2025953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two monoclonal anti-C4d reagents react with epitopes closely related to Rg:1 and Ch:1.
    Giles CM; Fielder AH; Lord DK; Robson T; O'Neill GJ
    Immunogenetics; 1987; 26(4-5):309-12. PubMed ID: 2443448
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-C4 in the serum of a transfused C4-deficient patient with systemic lupus erythematosus.
    Giles CM; Swanson JL
    Vox Sang; 1984; 46(5):291-9. PubMed ID: 6730425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
    Petersen NE; Teisner B; Folkersen J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chido and Rogers antigenic determinant on the fourth component of human complement.
    Chu VF; Marsh WL; Gigli I
    J Immunol; 1982 Jan; 128(1):181-5. PubMed ID: 6172476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
    Garratty G; Petz LD
    Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d.
    Freedman J; Mollison PL
    Vox Sang; 1976 Oct; 31(4):241-57. PubMed ID: 822586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.